C1086 Temozolomide - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Temozolomide

Brand Name:

Temodar

Strength:

5 mg

HCPCS:

C1086

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Alkylating Agent

Minor Drug Class:

Tetrazine

Oral (Y/N):

Yes

FDA Approval Year:

1999

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2010

CMS Discontinuation Date:

Status:

In Use